Helix BiopharmaHBP 
$0.7014.94%24h
14.94%24h
Global rank18217
Market cap$135.74M
Change 7d8.70%
YTD Performance376.19%
SP500 benchmarkOutperform
P/E-23.42
P/S0
Revenue$0
Earnings-$4.42M
Dividend yield-
Main Sector
Healthcare
Helix Biopharma (HBP) Total Liabilities
HBP Total Liabilities in 2022: $1.32M
According to Helix Biopharma latest financial reports the total liabilities of HBP is $1.32M, an decrease of -45.11% to 2022. At the end of 2022 company had $2.40M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Helix Biopharma is responsible for during its operational activities.
Helix Biopharma (HBP) Total Liabilities History from 2023 to 2022
-
Value:-
HBP Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $1.32M | -45.11% |
| 2022 | $2.40M | -37.49% |
| 2021 | $3.83M | 183.53% |
| 2020 | $1.35M | -39.16% |
| 2019 | $2.22M | - |
View the Top Total Liabilies Stocks
